Piafyrcaine

A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Piafyrcaine, a highly diluted version of Gailiamine, is used primarily in the management of insomnia and anxiety disorders due to its slower, more gradual sedative effects.

Piafyrcaine was developed as part of Advancer Enterprises' ongoing mission to provide more targeted and patient-friendly medications.

Piafyrcaine operates by modulating neurotransmitter activity in the brain, thereby inducing a calming effect. Its unique formulation allows for a slower onset of action, reducing the risk of sudden oversedation. This makes it particularly useful for patients requiring long-term treatment for insomnia or anxiety disorders. The drug is available in tablet form, with dosages ranging from 5mg to 20mg, allowing for personalized treatment plans.

Common side effects of Piafyrcaine include drowsiness, light-headedness, and mild cognitive impairment. In some cases, it can also cause dependence and withdrawal symptoms if used for an extended period and then suddenly stopped. As such, it's essential that the use of Piafyrcaine be closely monitored by a healthcare provider to ensure safe and effective treatment. Also, like other medications in its class, Piafyrcaine is not effective when inhaled.

An overdose of Piafyrcaine can lead to severe central nervous system depression, potentially resulting in coma or death. The overdose threshold is estimated to be around 100mg to 160mg. Immediate medical intervention is essential, often involving respiratory support and the administration of reversal agents like flumazenil.

Demibear created this article on 2023/10/09 23:53.

Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/